• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: FERRING PHARMACEUTICALS INC./ BIO-TECHNOLOGY GENERAL (ISRAEL) LTD. EUFLEXXA 20MG MILLIGRAM (S); ACID, HYALURONIC, INTRAARTICULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

FERRING PHARMACEUTICALS INC./ BIO-TECHNOLOGY GENERAL (ISRAEL) LTD. EUFLEXXA 20MG MILLIGRAM (S); ACID, HYALURONIC, INTRAARTICULAR Back to Search Results
Lot Number U14997A
Patient Problem Pain (1994)
Event Type  Other  
Event Description
Pt reports that she has not seen any change and she still gets pain and she feels that the euflexxa is not working.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EUFLEXXA 20MG MILLIGRAM (S)
Type of Device
ACID, HYALURONIC, INTRAARTICULAR
Manufacturer (Section D)
FERRING PHARMACEUTICALS INC./ BIO-TECHNOLOGY GENERAL (ISRAEL) LTD.
MDR Report Key17425641
MDR Text Key320149538
Report NumberMW5120373
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Nurse
Type of Report Initial
Report Date 07/27/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/28/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? No
Device Lot NumberU14997A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Patient Sequence Number1
Treatment
ADVIL
Patient Age46 YR
Patient SexFemale
Patient Weight95 KG
-
-